Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors
Risks
Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only
Sign up to access detailed risk analysis
About
Established in 2017 and headquartered in Seoul, South Korea, DK Life Science Co., Ltd. operates as a pharmaceutical enterprise focused on the creation and commercialization of diagnostic pharmaceuticals and medical instruments. The company extends its reach to markets across South Korea, the European Union, Japan, and other global territories. Its product portfolio encompasses a variety of items, including active pharmaceutical ingredients (APIs), injectable medications, personal blood glucose monitoring systems, mobile computed tomography (CT) devices, and ultrasonic equipment.